The proto-oncogene p120Cbl is a downstream substrate of the Hck protein-tyrosine kinase

被引:25
|
作者
Howlett, CJ
Bisson, SA
Resek, ME
Tigley, AW
Robbins, SM
机构
[1] Univ Calgary, Dept Oncol, Canc Biol & Immunol Res Grp, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Biochem & Mol Biol, Canc Biol & Immunol Res Grp, Calgary, AB T2N 4N1, Canada
关键词
D O I
10.1006/bbrc.1999.0427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic cell kinase (Hck) is a member of the Src-family of protein tyrosine kinases. We have found that upon enzymatic activation of lick by the heavy metal mercuric chloride, there was a rapid increase in the levels of tyrosine phosphorylation of several proteins including the proto-oncogene p120(Cbl). Fibroblasts that are transformed with an activated allele of Hck exhibit constitutive Cbl phosphorylation. Upon Fc gamma receptor activation, a more physiologically relevant extracellular signal, Cbl is tyrosine phosphorylated and the Src-family selective inhibitor, PP1, can prevent this phosphorylation on Cbl. Hck phosphorylates Cbl in vitro and the interaction between Cbl and Hck is direct, requiring Hck's unique, SH3 and SH2 domains for optimal binding. Using a novel estrogen-regulated chimera of Hck we have shown a hormone-dependent association between Hck and Cbl in murine fibroblasts. This work suggests that Cbl serves as a key mediator of Hck induced signalling in hematopoietic cells, (C) 1999 Academic Press.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 50 条
  • [31] Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
    Hu, Yun
    Revenko, Alexey
    Barsoumian, Hampartsoum
    Bertolet, Genevieve
    Fowlkes, Natalie Wall
    Maazi, Hadi
    Green, Morgan Maureen
    He, Kewen
    Sezen, Duygu
    Voss, Tiffany A.
    Leyton, Claudia S. Kettlun
    Masrorpour, Fatemeh
    Rafiq, Zahid
    Puebla-Osorio, Nahum
    Leuschner, Carola
    Macleod, Robert
    Cortez, Maria Angelica
    Welsh, James W.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [32] Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
    Yun Hu
    Alexey Revenko
    Hampartsoum Barsoumian
    Genevieve Bertolet
    Natalie Wall Fowlkes
    Hadi Maazi
    Morgan Maureen Green
    Kewen He
    Duygu Sezen
    Tiffany A. Voss
    Claudia S Kettlun Leyton
    Fatemeh Masrorpour
    Zahid Rafiq
    Nahum Puebla-Osorio
    Carola Leuschner
    Robert MacLeod
    Maria Angelica Cortez
    James W. Welsh
    Journal of Experimental & Clinical Cancer Research, 43
  • [33] The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk
    Miguel Garcia-Guzman
    Elise Larsen
    Kristiina Vuori
    Oncogene, 2000, 19 : 4058 - 4065
  • [34] The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk
    Garcia-Guzman, M
    Larsen, E
    Vuori, K
    ONCOGENE, 2000, 19 (35) : 4058 - 4065
  • [35] MODULATORY EFFECT OF THE TRANSMEMBRANE DOMAIN OF THE PROTEIN-TYROSINE KINASE ENCODED BY ONCOGENE ROS - BIOLOGICAL FUNCTION AND SUBSTRATE INTERACTION
    ZONG, CS
    WANG, LH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 10982 - 10986
  • [36] Proto-oncogene tyrosine-protein kinase SRC (Src) inhibition in microglia relieves neuroinflammation in neuropathic pain mouse models
    Cai, Yuanxing
    Xu, Jing
    Cheng, Qinghao
    BIOENGINEERED, 2021, 12 (02) : 11390 - 11398
  • [37] The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases
    Broome, MA
    Galisteo, ML
    Schlessinger, J
    Courtneidge, SA
    ONCOGENE, 1999, 18 (18) : 2908 - 2912
  • [38] The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases
    Martin A Broome
    Maria L Galisteo
    Joseph Schlessinger
    Sara A Courtneidge
    Oncogene, 1999, 18 : 2908 - 2912
  • [39] HUMAN PROTEIN-TYROSINE KINASE GENE HCK - EXPRESSION AND STRUCTURAL-ANALYSIS OF THE PROMOTER REGION
    LICHTENBERG, U
    QUINTRELL, N
    BISHOP, JM
    ONCOGENE, 1992, 7 (05) : 849 - 858
  • [40] The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation
    Lin, HM
    Martelli, MP
    Bierer, BE
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (01) : 13 - 22